The Pfizer/ BioNTech vaccine is now indicated for children aged six months to four years who have not yet received the third dose of the three-dose primary series with the monovalent Pfizer/BioNTech COVID-19 vaccine.
Meanwhile, Moderna’s bivalent vaccine is now authorised for children aged six months to five years as a single booster dose after completion of primary vaccination with the company’s monovalent vaccine.
